FDA okays more biotechnology products

被引：0

作者：

不详

机构：

来源：

BIOTECHNOLOGY LAW REPORT | 1997年 / 16卷 / 03期

关键词：

anticoagulants; Bard Diagnostic; bladder cancer; blood banks; haemonetics; international technidyne; osteoset bone graft substitute; Wright medical technologies;

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：353 / 354

页数：2

共 50 条

[41] FDA AND BIOTECHNOLOGY - UPDATE 1989
MILLER, HI
[J]. BIO-TECHNOLOGY, 1988, 6 (12): : 1385 - &
[42] Towards more effective FDA premarket review of new tobacco products
Myers, Matthew L.
[J]. TOBACCO CONTROL, 2016, 25 (03) : 243 - 244
[43] FDA okays augmentin extended-release and new hepatitis B drug
不详
[J]. INFECTIONS IN MEDICINE, 2002, 19 (11) : 506 - +
[44] FDA TO SPEED APPROVAL OF BIOTECHNOLOGY DRUGS
EMBER, L
[J]. CHEMICAL & ENGINEERING NEWS, 1992, 70 (11) : 6 - 6
[45] FDA okays live-attenuated, nasal spray form of flu vaccine
Cimons, M
[J]. ASM NEWS, 2003, 69 (09): : 426 - 427
[46] The FDA and the biotechnology industry: A symbiotic relationship?
Karwaki, TE
[J]. WASHINGTON LAW REVIEW, 1996, 71 (03) : 821 - 844
[47] FDA's policy on food biotechnology
Dietz, J
[J]. PLANT BIOTECHNOLOGY 2002 AND BEYOND, 2003, : 575 - 578
[48] BIOTECHNOLOGY, HUMAN-DISEASE, AND THE FDA
MELLON, M
[J]. SCIENCE, 1990, 250 (4979) : 359 - 360
[49] FDA to change regulation of biotechnology drugs
不详
[J]. BIOTECHNOLOGY LAW REPORT, 1996, 15 (01): : 27 - 28
[50] Two more biotechnology products gain orphan drug status - Products for organ transplantation, lung cancer
不详
[J]. BIOTECHNOLOGY LAW REPORT, 1998, 17 (06) : 771 - 772

← 1 2 3 4 5 →